Wed, Jan 20, 2021
The 52 Week Low is $2.61 set on Mon, Mar 16, 2020.
The 52 Week High is $5.27 set on Fri, Feb 21, 2020.
The All-Time High is $7.67 set on Wed, Sep 11, 2019.
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
Catalyst Pharmaceuticals Inc trades on the NASDAQ. CPRX's market cap is 360.00 Million.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome.